Pheton Holdings Ltd Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency
Pheton Holdings (NASDAQ: PTHL) disclosed receipt of a Nasdaq notice dated October 20, 2025, that its Class A ordinary shares no longer meet the Nasdaq minimum bid price requirement of $1.00 under Rule 5550(a)(2) based on the last 30 consecutive business days.
Nasdaq granted an initial 180-calendar-day compliance period ending April 20, 2026 to regain compliance. The company may be eligible for a second 180-day period if it meets market-value and other initial listing requirements (except the bid price) and provides notice to cure, potentially by effecting a reverse stock split. The company is evaluating options and intends to seek timely compliance but provided no assurance it will succeed.
Pheton Holdings (NASDAQ: PTHL) ha comunicato di aver ricevuto un avviso da Nasdaq datato 20 ottobre 2025, secondo il quale le sue azioni ordinarie di Classe A non soddisfano più il requisito minimo di prezzo di negoziazione di Nasdaq di 1,00 USD ai sensi della regola 5550(a)(2), basato sugli ultimi 30 giorni lavorativi consecutivi.
Nasdaq ha concesso un periodo iniziale di conformità di 180 giorni di calendario che termina 20 aprile 2026 per tornare in conformità. L'azienda potrebbe avere diritto a un secondo periodo di 180 giorni se soddisfa i requisiti di valore di mercato e altri requisiti iniziali di quotazione (eccetto il prezzo di offerta) e fornisce un avviso per correggere, eventualmente mediante una scissione azionaria inversa. L'azienda sta valutando opzioni e intende ottenere una conformità tempestiva, ma non ha fornito alcuna garanzia sul successo.
Pheton Holdings (NASDAQ: PTHL) divulgó haber recibido un aviso de Nasdaq con fecha del 20 de octubre de 2025, según el cual sus acciones ordinarias de Clase A ya no cumplen con el requisito mínimo de precio de oferta de Nasdaq de 1,00 USD conforme a la Regla 5550(a)(2), basado en los últimos 30 días hábiles consecutivos.
Nasdaq concedió un periodo inicial de cumplimiento de 180 días calendario que vence el 20 de abril de 2026 para volver a cumplir. La empresa podría ser elegible para un segundo periodo de 180 días si cumple con los requisitos de valor de mercado y otros requisitos iniciales de cotización (excepto el precio de oferta) y proporciona un aviso de subsanación, posiblemente mediante una regulación de división de acciones inversa. La empresa está evaluando opciones y tiene la intención de buscar un cumplimiento oportuno, pero no ha garantizado que lo logrará.
Pheton Holdings (NASDAQ: PTHL) 은 2025년 10월 20일자 나스닥 통지서를 받았다고 밝혔으며, 그 통지에 따르면 그들의 Class A 주식이 더 이상 Nasdaq의 $1.00의 최소 매수 가격 요건을 Rule 5550(a)(2)에 따라 충족하지 못하며, 이는 지난 30거래일의 연속 기간을 기준으로 합니다.
나스닥은 180일 캘린더 기간의 초기 준수 기간을 부여했고, 이는 2026년 4월 20일에 종료되어 준수를 회복하기 위한 것입니다. 회사는 시가 가치 및 다른 초기 상장 요건(매수가격 제외)을 충족하고 시정 공지를 제공하면 두 번째 180일 기간을 얻을 자격이 있을 수 있으며, 역분할(Reverse Stock Split)을 통해 시정할 수 있습니다. 회사는 옵션을 평가 중이며 시의적절한 준수를 추구할 의향이 있지만 성공을 보장하지는 않습니다.
Pheton Holdings (NASDAQ: PTHL) a déclaré avoir reçu un avis de Nasdaq daté du 20 octobre 2025, indiquant que ses actions ordinaires de classe A ne respectent plus l’exigence de prix d’offre minimale de Nasdaq de 1,00 USD selon la règle 5550(a)(2), sur la base des 30 derniers jours ouvrables consécutifs.
Nasdaq a accordé une période initiale de conformité de 180 jours calendaires qui se termine le 20 avril 2026 pour rétablir la conformité. L’entreprise pourrait être éligible à une seconde période de 180 jours si elle satisfait les exigences de valeur marchande et d’autres exigences initiales de cotation (à l’exception du prix d’offre) et fournit un avis de remède, potentiellement par une scission d’actions inversée. L’entreprise évalue des options et a l’intention de rechercher une conformité en temps utile mais n’a donné aucune garantie de réussite.
Pheton Holdings (NASDAQ: PTHL) gab bekannt, einen Nasdaq-Hinweis vom 20. Oktober 2025 erhalten zu haben, wonach seine Class A Stammaktien nicht mehr die Nasdaq-Minimalpreis-Anforderung von 1,00 USD gemäß Regel 5550(a)(2) erfüllt, basierend auf den letzten 30 aufeinanderfolgenden Handelstagen.
Nasdaq hat eine anfängliche 180-Tage-Kalender-Compliance-Periode gewährt, die am 20. April 2026 endet, um die Compliance wiederherzustellen. Das Unternehmen könnte für eine zweite 180-Tage-Periode berechtigt sein, wenn es die Marktwert- und weiteren initialen Listing-Anforderungen (ausgenommen den Angebotspreis) erfüllt und eine Korrekturanzeige vorlegt, möglicherweise durch eine Reverse Stock Split. Das Unternehmen prüft Optionen und beabsichtigt, zeitnah konform zu werden, hat jedoch keine Garantie für Erfolg gegeben.
Pheton Holdings (NASDAQ: PTHL) أعلنت أنها تلقت إشعاراً من Nasdaq بتاريخ 20 أكتوبر 2025 يفيد بأن أسهمها العادية من الفئة A لم تعد تفي بالمتطلب الأدنى لسعر العرض من Nasdaq البالغ 1.00 دولار وفق القاعدة 5550(a)(2)، اعتماداً على آخر 30 يوماً عملياً متتالية.
منحت Nasdaq فترة امتثال ابتدائية لمدة 180 يوماً تقويمياً تنتهي في 20 أبريل 2026 لاستعادة الامتثال. قد تكون الشركة مؤهلة لفترة ثانية من 180 يوماً إذا استوفت متطلبات القيمة السوقية وغيرها من متطلبات الإدراج الأولية (باستثناء سعر العرض) و قدّمت إشعاراً بالتصحيح، وربما عبر إجراء التحويل العكسي للأسهم. الشركة تقيم الخيارات وتعتزم السعي للامتثال في الوقت المناسب لكنها لم تقدم تأكيداً أنها ستنجح.
Pheton Holdings (NASDAQ: PTHL) 披露已收到 NASDAQ 于 2025年10月20日 发出的通知，称其 Class A 普通股 不再符合 Nasdaq 的最低买入价要求 1.00 美元，依据规则 5550(a)(2)，基于最近的 30个连续交易日。
Nasdaq 授予初始 180 个日历日 的合规期，结束于 2026 年 4 月 20 日，以重新达到合规。若公司符合市值及其他初始上市要求（不包括买入价）并发出纠正通知，可能有资格获得第二个 180 日 的合规期，且可能通过实施 反向股票分割 来纠正。公司正在评估选项，打算寻求及时合规，但未对能否成功作出保证。
- Nasdaq granted a 180-day compliance period ending April 20, 2026
- Potential eligibility for a second 180-day period if market-value tests are met
- Company's Class A shares closed below the $1.00 minimum for 30 consecutive business days
- Possible reverse stock split may be required to cure bid-price deficiency
- Risk of delisting if compliance is not achieved within available cure periods
Insights
Pheton received a Nasdaq notice for failing the
The company, Pheton Holdings Ltd, failed to meet Nasdaq Listing Rule 5550(a)(2) because the closing bid price fell below
Key dependencies and risks include successful restoration of the bid price within the compliance period and meeting other Nasdaq listing standards if a second extension is sought. If the company cannot cure the deficiency or is ineligible for extension, Nasdaq may issue a delisting notice. Watch for concrete milestones such as any announced reverse split, short-term price movement that restores the closing bid above
Beijing, China, Oct. 23, 2025 (GLOBE NEWSWIRE) -- Pheton Holdings Ltd (NASDAQ: PTHL) (the “Company”), a healthcare solution provider specializing in treatment planning systems for brachytherapy and other related products and services, today announced, on October 20, 2025, the Company received a letter from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that based on the closing bid price of the Class A ordinary shares of the Company for the last 30 consecutive business days, the Company no longer meets the continued listing requirement of Nasdaq under Nasdaq Listing Rules 5550(a)(2), to maintain a minimum bid price of
The notification has no immediate effect on the listing or trading of the Company’s Class A ordinary shares on Nasdaq. Nasdaq has provided the Company with an 180 calendar days compliance period, or until April 20, 2026, in which to regain compliance with Nasdaq continued listing requirement. In the event that the Company does not regain compliance in the compliance period, the Company may be eligible for an additional 180 calendar days, should the Company meet the continued listing requirement for market value of publicly held shares and all other initial listing standards for The Nasdaq Capital Market, with the exception of the bid price requirement, and is able to provide written notice of its intention to cure the deficiency during the second compliance period, by effecting a reverse stock split, if necessary. However, if it appears that the Company will not be able to cure the deficiency, or if the Company is otherwise not eligible, Nasdaq will provide notice that the Company’s securities will be subject to delisting.
The Company is currently evaluating options to regain compliance and intends to timely regain compliance with Nasdaq’s continued listing requirement. Although the Company will use all reasonable efforts to achieve compliance with Rule 5550(a)(2), there can be no assurance that the Company will be able to regain compliance with that rule or will otherwise be in compliance with other Nasdaq continued listing requirement.
About Pheton Holdings Ltd
Founded in 1998, Pheton Holdings Ltd, through its wholly owned operating subsidiary, Beijing Feitian Zhaoye Technology Co., Ltd., focuses on healthcare solutions for brachytherapy, a targeted radiation therapy used in cancer treatment. Its lead product, Beijing Feitian’s Treatment Planning System, helps ensure safe and effective brachytherapy using radioactive sources inside the patient to kill cancer cells and shrink tumors. Pheton Holdings is committed to leveraging its products and services to establish a potential new standard of care across multiple malignant tumor applications. For more information, please visit: http://www.ftzy.com.cn/ir.
Forward-Looking Statements
This press release contains forward-looking statements. These statements are made under the “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995. Statements that are not historical facts, including statements about the Company’s beliefs and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties, and a number of factors could cause actual results to differ materially from those contained in any forward-looking statement. In some cases, forward-looking statements can be identified by words or phrases such as “may,” “will,” “expect,” “anticipate,” “target,” “aim,” “estimate,” “intend,” “plan,” “believe,” “potential,” “continue,” “is/are likely to” or other similar expressions. The Company may also make written or oral forward-looking statements in its reports filed with, or furnished to, the U.S. Securities and Exchange Commission, in its annual reports to shareholders, in press releases and other written materials and in oral statements made by its officers, directors or employees to third parties. These statements are subject to uncertainties and risks including, but not limited to, the following: the Company’s goals and strategies; the Company’s future business development; financial condition and results of operations; product and service demand and acceptance; reputation and brand; the impact of competition and pricing; changes in technology; government regulations; fluctuations in general economic and business conditions in U.S., Hong Kong and China and assumptions underlying or related to any of the foregoing and other risks contained in reports filed by the Company with the SEC. For these reasons, among others, investors are cautioned not to place undue reliance upon any forward-looking statements in this press release. Additional factors are discussed in the Company’s filings with the SEC, which are available for review at www.sec.gov. The Company undertakes no obligation to publicly revise these forward-looking statements to reflect events or circumstances that arise after the date hereof.
For investor and media inquiries, please contact:
Pheton Holdings Ltd
Investor Relations
Email: ir@ftzy.com.cn
Jackson Lin
Lambert Global
Tel: +1 (646) 717-4593
Email: jlin@lambert.com
FAQ
What did PTHL announce about Nasdaq minimum bid price on October 20, 2025?
How long does PTHL have to regain Nasdaq compliance for symbol PTHL?
Can PTHL get more time after the initial Nasdaq compliance period?
What actions might PTHL take to cure the Nasdaq bid-price deficiency?
Does the Nasdaq notice affect PTHL trading immediately?
